Ben Z Stanger

63PUBLICATIONS
377CO-AUTHORS
Molecular targetsTumour immunologyCancer diagnosisHaematological tumoursChemical and thermal processes in energy and combustion
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (63)

|Jun 12, 2026
Mono-ADP-ribosylation-driven immunosuppression and cross-resistance to therapy through cancer cell intrinsic and extrinsic mechanisms.

|Apr 10, 2026
SPTBN2 promotes an immunosuppressive tumor microenvironment and cross-resistance to anti-cancer therapies.

Quoc Thang Bui, Raghavendra Basavaraja, Mayura R Dhamdhere

|Mar 12, 2026
Cancer interception with KRAS inhibitors in preclinical models of pancreatic ductal adenocarcinoma.

Minh T Than, Lucie Dequiedt, Rina Sor

|Feb 05, 2026
KRAS Inhibitors in Pancreas Cancer: Facts and Hopes about the Immunotherapy We Have All Been Waiting for.

Ben Z Stanger, Robert H Vonderheide

|Dec 22, 2025
TMEM Doorway Mediated Metastasis in Pancreatic Ductal Adenocarcinoma by Tie2 Signaling.

Erika Pereira Zambalde, Lina A Ariyan, Francisco Puerta-Martinez

|Nov 25, 2025
Plastic hepatocyte states limit liver cancer development.

Lauren S Strathearn, Yuki Hayata, Abhinav Illendula

Pageof 11

Frequent Collaborators

11 joint publications

Jinyang Li

9 joint publications

Robert Vonderheide

6 joint publications

Andrew J Aguirre

6 joint publications

Cynthia Clendenin